Recent work in mouse models of SLE has demonstrated that STING is required for homeostatic expression of negative regulators of immune activation (5) while analysis of human monocytes from SLE patients revealed a hyperactive STING signaling that is regulated by the IFN-induced gene, IFIT3 (24). This evidence concerns the gene STING1 and systemic lupus erythematosus.